Which Starting Dose Strategy Suits Your Goals?
Wegovy vs Mounjaro Dosing: Understanding Your Starting Options
When comparing Wegovy vs Mounjaro dosing protocols, the fundamental difference begins with their respective starter approaches. Wegovy utilises a methodical 0.25mg starting dose administered once weekly for the first four weeks, designed to allow your body to gradually adapt to semaglutide's GLP-1 receptor activation. Mounjaro, conversely, begins with a 2.5mg weekly dose of tirzepatide, targeting both GIP and GLP-1 receptors simultaneously from the outset. This dual-agonist mechanism means Mounjaro's starting dose delivers a fundamentally different physiological response compared to Wegovy's singular GLP-1 pathway activation.
The Wegovy vs Mounjaro dosing comparison reveals distinct escalation timelines that may influence your choice. Wegovy follows a structured 16-week progression (0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg maintenance), with each dose phase lasting exactly four weeks before advancing. Mounjaro's escalation occurs every four weeks as well, but progresses through different dose strengths (2.5mg → 5mg → 7.5mg → 10mg → 15mg maximum). Both medications require this gradual approach to minimise gastrointestinal side effects whilst optimising therapeutic benefit. Your prescriber will determine which starting protocol aligns with your medical history and weight management objectives.
Pricing Structure: Wegovy vs Mounjaro Dosing Cost Analysis
Understanding the financial implications of Wegovy vs Mounjaro dosing requires examining each medication's cost structure from initiation through maintenance phases. Wegovy starter doses begin at £79.99 for the 0.25mg strength, with our FIRST40 discount code automatically applied at checkout for new patients. Returning customers benefit from the DOSE25 code for ongoing treatment. Our Intro Duo bundle provides both 0.25mg and 0.5mg strengths for £169.99, covering your first eight weeks of treatment with convenient single-order delivery.
The Wegovy vs Mounjaro dosing cost comparison extends beyond starter pricing to encompass the full treatment journey. Wegovy escalation costs progress through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), reaching £209.99 for the 2.4mg maintenance dose. Mounjaro follows its own pricing structure, available separately through our clinical assessment process. Both medications represent significant investment in your weight management journey, supported by comprehensive prescriber oversight and cold-chain pharmaceutical delivery. EverydayMeds provides flexible bundle options to ensure treatment continuity whilst managing your budget effectively throughout the dosing progression.
Clinical Evidence Supporting Wegovy vs Mounjaro Dosing Protocols
The scientific foundation for Wegovy vs Mounjaro dosing strategies stems from extensive clinical trial programmes demonstrating each medication's efficacy profile. Wegovy's evidence base, primarily derived from the STEP trial series including Wilding et al., NEJM, 2021, showed that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in STEP 1. The dosing escalation protocol used in these trials forms the basis for current prescribing guidelines, validating the 16-week titration approach.
Mounjaro's clinical evidence comes from the SURMOUNT trials, which utilised the medication's specific dual-agonist dosing protocol to demonstrate efficacy outcomes. When comparing Wegovy vs Mounjaro dosing approaches, both medications showed meaningful weight loss results in their respective trial populations, though direct head-to-head comparisons aren't available due to different trial designs and patient populations. Your prescriber will review this clinical evidence alongside your individual circumstances to determine which dosing approach may be more suitable for your weight management goals.
How Wegovy's Mechanism Influences Dosing Requirements
Wegovy's dosing protocol directly relates to its mechanism as a GLP-1 receptor agonist that mimics your body's natural incretin hormones. The medication works by binding to GLP-1 receptors in the brain's appetite control centres, promoting feelings of satiety whilst reducing overall food cravings. This mechanism requires gradual dose escalation to allow your GLP-1 receptors to adapt progressively, minimising potential gastrointestinal side effects such as nausea or stomach discomfort. The 0.25mg starting dose provides sufficient GLP-1 activation to begin therapeutic benefits whilst maintaining tolerability for most patients. As your body adapts to each dose level, the structured escalation ensures continued efficacy throughout your weight management journey, ultimately reaching the 2.4mg maintenance dose that provides optimal GLP-1 receptor activation for sustained appetite regulation.
Streamlined Ordering Process for Wegovy vs Mounjaro Dosing
Accessing either Wegovy or Mounjaro through EverydayMeds begins with our comprehensive 3-minute online clinical assessment, designed to capture your medical history, current medications, and weight management objectives. Our qualified prescribers review your submission within three working days (or 24 hours with express service), evaluating which medication and dosing approach aligns with your clinical profile. Once approved, your prescription undergoes pharmaceutical preparation at our GPhC-registered facility (#9012878), with cold-chain packaging maintaining medication integrity during transport. Next-day delivery ensures you receive your starter dose promptly, accompanied by detailed administration guidance and ongoing clinical support. Our prescribers remain available throughout your treatment journey, monitoring your progress and adjusting dosing recommendations as needed to optimise your weight management outcomes.
Storage and Administration: Wegovy vs Mounjaro Dosing Practicalities
Practical considerations for Wegovy vs Mounjaro dosing extend beyond clinical efficacy to encompass storage requirements and administration logistics. Wegovy arrives in pre-filled FlexTouch pens requiring refrigerated storage at 2–8°C before first use, with the significant advantage of maintaining stability for up to six weeks at room temperature below 30°C once removed from refrigeration. This storage flexibility surpasses Mounjaro's 21-day room temperature limit, making Wegovy particularly suitable for patients who travel frequently or require dosing flexibility. Both medications utilise once-weekly subcutaneous injection, typically administered on the same day each week to maintain consistent therapeutic levels. The dose escalation schedule cannot be accelerated or modified without prescriber guidance, as the structured progression ensures optimal tolerability whilst building therapeutic efficacy over time.
First-Time Patient Considerations for Wegovy vs Mounjaro Dosing
New patients evaluating Wegovy vs Mounjaro dosing options benefit from understanding each medication's unique characteristics during the initial treatment phases. Wegovy's 0.25mg starting dose provides a gentle introduction to GLP-1 therapy, with most patients experiencing gradual appetite reduction and enhanced satiety signals within the first few weeks. The structured four-week phases allow your body to adapt progressively, with side effects typically diminishing as you advance through each dose level. Our Gentle Start Trio bundle (0.25mg, 0.25mg, 0.5mg) accommodates patients preferring extended time at the initial dose before escalation.
First-time patients often appreciate Wegovy's established dosing pathway, which provides clear expectations for their treatment journey from initiation through maintenance phases. Unlike some weight management approaches that require frequent dose adjustments, Wegovy vs Mounjaro dosing follows predetermined schedules that simplify treatment planning and reduce uncertainty. Your EverydayMeds prescriber will discuss realistic expectations for each dose phase, including potential side effects, therapeutic timeline, and long-term maintenance strategies. This comprehensive approach ensures you feel confident and supported throughout your weight management journey, regardless of which medication proves most suitable for your individual circumstances.
Secure Your Wegovy Starter Dose Today
Beginning your weight management journey with Wegovy starts with selecting your preferred starter option from our comprehensive range of dosing packages. New patients can access the 0.25mg starter dose for £79.99 using discount code FIRST40 at checkout, or choose our Intro Duo bundle for extended initial supply at £169.99. Our 3-minute clinical assessment connects you with qualified prescribers who specialise in weight management therapy, ensuring your chosen approach aligns with your medical history and treatment objectives. All orders include cold-chain delivery within 24 hours of approval, comprehensive administration guidance, and ongoing clinical support throughout your dose escalation journey. EverydayMeds remains committed to providing exceptional pharmaceutical care through our GPhC-registered service (#9012878), supporting your weight management success with professional oversight and premium medication quality.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
